Document text
Principal Investigator: David W Haas
Organization: VANDERBILT UNIVERSITY MEDICAL CENTER
Fiscal Year: 2020
Award: $558,406
Funding agency: National Institute of Allergy and Infectious Diseases
Project Summary
Coronavirus disease 2019 (COVID-19) pandemic caused by Severe Acute Respiratory Syndrome coronavirus
2 (SARS-CoV-2) required a rapid, coordinated response. The pandemic has interfered with many other important
endeavors, including NIH-sponsored non-COVID HIV clinical trials. We need robust plans to implement
measures to expand SARS-CoV-2, allowing research units to resume studies being conducted on HIV, while
maintaining the safety and well-being of participants and staff. To this end, we have developed strategies relying
on a combination of testing for active disease, evaluating seroprevalence, and conducting operations in ways
that enforce social distancing and utilization of personal protective equipment (PPE). This project is being
implemented at the Vanderbilt Therapeutics Clinical Research Site (VT-CRS), and the Washington University
Prevention & Therapeutics (WPT) CRS. This strategy will comprise two aims that involve research participants,
their household contacts, and staff: Aim 1) To utilize resources obtained through this administrative supplement
to expand SARS-CoV-2 testing within the regions of our Clinical Research Sites; and Aim 2) To utilize resources
obtained through this administrative supplement to more quickly and fully resume on-site research activities at
our Clinical Research Sites. Among the activities to be implemented are universal testing of study participants
for infection by SARS-CoV-2 PCR prior to study visits, either by staff during parking lot drive-through visits or self-
collected remotely by study participants. At one CRS, testing will also be offered to adult household contacts of
study participants. There will be active screening for symptoms of COVID-19. There will be SARS-CoV-2 antibody
testing at the beginning and end of the project period, of staff and/or study participants. This project will
substantially expanding SARS-CoV-2 testing, and expedite the opening of our NIAID-funded CRSs. In addition, the
experience and information gained during this project will inform future strategies to further expand testing and
facilitate clinical trials operations.
Terms: <2019 novel coronavirus><2019-nCoV><21+ years old><AIDS Virus><Academic Medical Centers><Acquired Immune Deficiency Syndrome Virus><Acquired Immunodeficiency Syndrome Virus><Active Follow-up><Administrative Supplement><Adult><Adult Human><Antibodies><Antigens><Area><Businesses><COVID-19><COVID-19 epidemic><COVID-19 pandemic><COVID19><COVID19 epidemic><COVID19 pandemic><Caring><Clinical Research><Clinical Study><Clinical Trials><Collection><Communicable Disease Contact Tracing><Communicable Diseases><Conchae Nasales><Contact Tracing><Cooperative Agreements><Coughing><Coupled><Data><Diagnostic tests><Disease><Disease Outbreaks><Disorder><Ensure><Environment><Epidemic><Epidemiology><Equipment><Evaluation><Fever><Funding><Funding Opportunities><Future><Grant><HIV><Health Care Providers><Health Care Systems><Health Care Utilization><Health Personnel><Healthcare><Healthcare Providers><Healthcare Systems><Healthcare worker><Hour><Household><Human Immunodeficiency Viruses><Individual><Infection><Infection Control><Infectious Disease Contact Tracing><Infectious Disease Pathway><Infectious Diseases><Infectious Disorder><LAV-HTLV-III><Location><Lymphadenopathy-Associated Virus><M tuberculosis infection><M. tb infection><M. tuberculosis infection><M.tb infection><M.tuberculosis infection><MTB infection><Malaise><Masks><Measures><Medical Records><Morbidity><Morbidity - disease rate><Mycobacterium tuberculosis (MTB) infection><Mycobacterium tuberculosis infection><NIAID><NIH><Nasal><Nasal Passages Nose><Nasal turbinate bone structure><National Institute of Allergy and Infectious Disease><National Institutes of Health><Nose><Occupational Health><Outbreaks><Participant><Patients><Personal Satisfaction><Play><Population><Prevention><Pyrexia><Recommendation><Research><Research Activity><Research Resources><Research Specimen><Resistance><Resources><Respiratory Infections><Respiratory System, Nose, Nasal Passages><Respiratory Tract Infections><Role><SARS-CoV-2><SARS-CoV2><SARS-associated coronavirus 2><SARS-coronavirus-2><SARS-related coronavirus 2><Safety><Schedule><Serologic tests><Serological Tests><Seroprevalences><Severe acute respiratory syndrome coronavirus 2><Sexually Transmitted Diseases><Sexually Transmitted Disorder><Sexually Transmitted Infection><Shortness of Breath><Site><Social Distance><Specimen><Sputum><Swab><Symptoms><Syndrome><TB infection><Tennessee><Testing><Therapeutic><Treatment Efficacy><Tuberculosis><Turbinates><U-Series Cooperative Agreements><United States><United States National Institutes of Health><Universities><University Medical Centers><Vaccines><Venereal Diseases><Venereal Disorders><Venereal Infections><Virus-HIV><Visit><Washington><Wuhan coronavirus><active followup><adulthood><base><clinical research site><clinical site><common symptom><corona virus disease 2019><corona virus disease 2019 epidemic><corona virus disease 2019 pandemic><coronavirus disease 2019><coronavirus disease 2019 epidemic><coronavirus disease 2019 pandemic><disseminated TB><disseminated tuberculosis><epidemiologic><epidemiological><experience><febrile><febris><follow up><follow-up><followed up><followup><health care><health care personnel><health care service use><health care service utilization><health care worker><health provider><health workforce><healthcare personnel><healthcare service use><healthcare service utilization><healthcare utilization><immunogen><infection due to Mycobacterium tuberculosis><intervention efficacy><medical personnel><mortality><operation><pandemic><pandemic disease><resistant><respiratory><response><sample collection><scale up><screening><serology><social role><specimen collection><success><therapeutic efficacy><therapeutically effective><therapy efficacy><treatment provider><tuberculosis infection><tuberculous spondyloarthropathy><well-being><wellbeing>